The 2019 novel coronavirus, which causes coronavirus disease (COVID-19), should be coded with the ICD-10 code B97.29, other coronavirus as the cause of diseases classified elsewhere.
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. New research looked
Mortality was lower in diabetes patients given sitagliptin at admission for COVID-19, ACP practice points support remdesivir, acquired thrombophilia does not predict clots, cardiac arrest survival is low, and admissions for other conditions were
This is a randomized, blinded, controlled trial looking at plasma with high titers against coronavirus compared to regular plasma. ... In Maryland, I believe there were several hundred new cases of coronavirus that happened yesterday.
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
Several journal articles described recently implemented strategies for isolation, education, testing, visitors, and staff support, while others called for research collaboration and support for female hospitalists.
Recent studies showed that the risk of catching SARS-CoV-2 in a hospital is low for patients and varies by job and preventive measures for health care workers. A model and a serology study identified patients with worse outcomes from COVID-19.
Updates to the FDA's Coronavirus Treatment Acceleration Program webpage.
Somewhere deep inside, there was hope that the need to apply this information might never arrive.
Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.